| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.62 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |